These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 34307679)

  • 1. Identifying COVID-19-Specific Transcriptomic Biomarkers with Machine Learning Methods.
    Chen L; Li Z; Zeng T; Zhang YH; Feng K; Huang T; Cai YD
    Biomed Res Int; 2021; 2021():9939134. PubMed ID: 34307679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying Transcriptomic Signatures and Rules for SARS-CoV-2 Infection.
    Zhang YH; Li H; Zeng T; Chen L; Li Z; Huang T; Cai YD
    Front Cell Dev Biol; 2020; 8():627302. PubMed ID: 33505977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional Profiling and Machine Learning Unveil a Concordant Biosignature of Type I Interferon-Inducible Host Response Across Nasal Swab and Pulmonary Tissue for COVID-19 Diagnosis.
    Zhang C; Feng YG; Tam C; Wang N; Feng Y
    Front Immunol; 2021; 12():733171. PubMed ID: 34880855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Transcriptome Biomarkers for Severe COVID-19 with Machine Learning Methods.
    Li X; Zhou X; Ding S; Chen L; Feng K; Li H; Huang T; Cai YD
    Biomolecules; 2022 Nov; 12(12):. PubMed ID: 36551164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of key genes associated with persistent immune changes and secondary immune activation responses induced by influenza vaccination after COVID-19 recovery by machine learning methods.
    Ren J; Zhou X; Huang K; Chen L; Guo W; Feng K; Huang T; Cai YD
    Comput Biol Med; 2024 Feb; 169():107883. PubMed ID: 38157776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmentation of Transcriptomic Data for Improved Classification of Patients with Respiratory Diseases of Viral Origin.
    Kircher M; Chludzinski E; Krepel J; Saremi B; Beineke A; Jung K
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying novel host-based diagnostic biomarker panels for COVID-19: a whole-blood/nasopharyngeal transcriptome meta-analysis.
    Maleknia S; Tavassolifar MJ; Mottaghitalab F; Zali MR; Meyfour A
    Mol Med; 2022 Aug; 28(1):86. PubMed ID: 35922752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity in transmissibility and shedding SARS-CoV-2 via droplets and aerosols.
    Chen PZ; Bobrovitz N; Premji Z; Koopmans M; Fisman DN; Gu FX
    Elife; 2021 Apr; 10():. PubMed ID: 33861198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Novel COVID-19 Biomarkers by Multiple Feature Selection Strategies.
    Zhang S; Qu R; Wang P; Wang S
    Comput Math Methods Med; 2021; 2021():2203636. PubMed ID: 34603483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cochrane corner: universal screening for SARS-CoV-2 infection.
    Ndwandwe D; Mathebula L; Adetokunboh O; Kamadjeu R; Wiysonge CS
    Pan Afr Med J; 2020; 37(Suppl 1):48. PubMed ID: 33552376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive analysis of gene expression profiling data in COVID-19 patients for discovery of specific and differential blood biomarker signatures.
    Momeni M; Rashidifar M; Balam FH; Roointan A; Gholaminejad A
    Sci Rep; 2023 Apr; 13(1):5599. PubMed ID: 37019895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorimetric reverse transcription loop-mediated isothermal amplification (RT-LAMP) as a visual diagnostic platform for the detection of the emerging coronavirus SARS-CoV-2.
    Nawattanapaiboon K; Pasomsub E; Prombun P; Wongbunmak A; Jenjitwanich A; Mahasupachai P; Vetcho P; Chayrach C; Manatjaroenlap N; Samphaongern C; Watthanachockchai T; Leedorkmai P; Manopwisedjaroen S; Akkarawongsapat R; Thitithanyanont A; Phanchana M; Panbangred W; Chauvatcharin S; Srikhirin T
    Analyst; 2021 Jan; 146(2):471-477. PubMed ID: 33165486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers and Immune Repertoire Metrics Identified by Peripheral Blood Transcriptomic Sequencing Reveal the Pathogenesis of COVID-19.
    Liu Y; Wu Y; Liu B; Zhang Y; San D; Chen Y; Zhou Y; Yu L; Zeng H; Zhou Y; Zhou F; Yang H; Yin L; Huang Y
    Front Immunol; 2021; 12():677025. PubMed ID: 34504487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered microRNA expression in COVID-19 patients enables identification of SARS-CoV-2 infection.
    Farr RJ; Rootes CL; Rowntree LC; Nguyen THO; Hensen L; Kedzierski L; Cheng AC; Kedzierska K; Au GG; Marsh GA; Vasan SS; Foo CH; Cowled C; Stewart CR
    PLoS Pathog; 2021 Jul; 17(7):e1009759. PubMed ID: 34320031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host-dependent molecular factors mediating SARS-CoV-2 infection to gain clinical insights for developing effective targeted therapy.
    Shafi G; Desai S; Srinivasan K; Ramesh A; Chaturvedi R; Uttarwar M
    Mol Genet Genomics; 2021 May; 296(3):501-511. PubMed ID: 33743061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automated machine learning optimizes and accelerates predictive modeling from COVID-19 high throughput datasets.
    Papoutsoglou G; Karaglani M; Lagani V; Thomson N; Røe OD; Tsamardinos I; Chatzaki E
    Sci Rep; 2021 Jul; 11(1):15107. PubMed ID: 34302024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Machine learning-driven blood transcriptome-based discovery of SARS-CoV-2 specific severity biomarkers.
    Krishnamoorthy P; Raj AS; Kumar H
    J Med Virol; 2023 Feb; 95(2):e28488. PubMed ID: 36625381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing two sample pooling strategies for SARS-CoV-2 RNA detection for efficient screening of COVID-19.
    Chen F; Geng Z; Wang J; Liuchang W; Huang D; Xu Y; Wang Z; Wang L
    J Med Virol; 2021 May; 93(5):2805-2809. PubMed ID: 33107614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recognition of Immune Cell Markers of COVID-19 Severity with Machine Learning Methods.
    Chen L; Mei Z; Guo W; Ding S; Huang T; Cai YD
    Biomed Res Int; 2022; 2022():6089242. PubMed ID: 35528178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic comparison of published host gene expression signatures for bacterial/viral discrimination.
    Bodkin N; Ross M; McClain MT; Ko ER; Woods CW; Ginsburg GS; Henao R; Tsalik EL
    Genome Med; 2022 Feb; 14(1):18. PubMed ID: 35184750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.